← Database
M&A

MARLE GROUP

Acquired by

IK PARTNERS

FRANCE Life Sciences EV [100m EUR - 500m EUR] 05/2016

Target

MARLE GROUP

Acquirer

IK PARTNERS

Context

IK Investment Partners has agreed to acquire a majority stake in Marle International from Carlyle Europe Technology. The transaction values the company at approximately EUR350 million. This "Limited Auction" process saw IK prevail over competitors Astorg, Permira, and Ergon. As part of the deal, Carlyle reinvests as a minority shareholder, alongside the founding Marle family and the management team. The acquisition aims to support Marle's continued international expansion and external growth strategy.

MARLE GROUP, which reported an EBITDA margin of LOGIN in 2015, is valued in this transaction at an EV/EBITDA multiple of LOGIN, representing a LOGIN premium to the 12.8x average currently observed in the Healthcare & Pharma sector.

Note that this data is based on contribution from our growing community, composed of M&A and Private Equity professionals, and has been verified by our team to ensure its accuracy.

-> Deep-dive in Healthcare & Pharma market trends

Target

Marle Group is a European leader in the manufacturing of orthopedic, trauma, and spine implants. Backed by the family investment holding Dentressangle, Marle operates as a Contract Development and Manufacturing Organization (CDMO) for major global medical device companies.

Ent. Value

LOGIN

Equity Value

LOGIN

Multiples Analysis

EV / Revenue

LOGIN

EV / EBITDA

LOGIN

EV / EBIT

LOGIN

Historical Financials (EUR)

Year
Rev
EBITDA
EBIT
2015
LOGIN
LOGIN
LOGIN
2014
LOGIN
LOGIN
LOGIN

Other operations with MARLE GROUP

DateAcquirerTargetCountrySectorDeal Context
12/2023MARLE GROUPNOWAKFRANCEImplants & Prosthetics

Marle Group has acquired Nowak from a consortium of private equity investors led by Siparex Midcap, alongside Bpifrance, Unexo, and the management team. This acquisition strengthens Marle's vertical integration by adding specialized casting capabilities. The deal follows a successful transformation period under Siparex (2018-2023), where Nowak shifted its focus toward the medical sector and acquired Belmonte. The transaction was financed via a unitranche debt facility provided by Capza.

10/2019DENTRESSANGLEMARLE GROUPFRANCEImplants & Prosthetics

Dentressangle has entered into exclusive negotiations to acquire a majority stake in Marle Group from IK Investment Partners. The deal was preemptive

09/2009THE CARLYLE GROUPMARLE GROUPFRANCEImplants & Prosthetics

The Carlyle Group has acquired an 80% majority stake in Marle S.A. The company's President, Bernard Marle, along with his family, has reinvested to retain a 20% stake. This Primary LBO is designed to support the company's growth in a market expanding at 8% annually. The transaction structure includes a senior debt package co-arranged by CIC Est and LCL, as well as a vendor loan (credit-vendeur). Carlyle aims to professionalize the company and accelerate its international expansion.

mynth data is contributed by M&A / PE professionals and systematically cross-verified against private deal documents and official releases. All source materials are destroyed post-validation to guarantee data anonymity and compliance.